Knowledge and News for the Global Fight Against Cancer.
While chief executives at S&P 500 companies generally experienced a median salary increase of approximately...
Belgian biopharmaceutical giant UCB announced Friday a definitive agreement to acquire Neurona Therapeutics, a privately...
The biopharmaceutical landscape witnessed a flurry of significant developments this past week, ranging from the...
Kailera Therapeutics, a formidable new entrant in the pharmaceutical landscape poised to challenge industry giants...
The Food and Drug Administration (FDA) is set to convene a series of advisory committee...
Eli Lilly’s newly approved oral obesity medication, Foundayo (orforglipron), has been subjected to significant post-market...
California-based Terremoto Biosciences has successfully closed a substantial $75 million Series A financing round, positioning...
Emerging from stealth on Wednesday, April 15, 2026, Beeline Medicines announced its official launch, fortified...
Johnson & Johnson, the global healthcare behemoth, announced a stellar first-quarter performance for 2026, significantly...
The recent clearance of Filspari (sparsentan) by the U.S. Food and Drug Administration (FDA) for...
admin